Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 24.2 EUR -3.01% Market Closed
Market Cap: 294.3m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SBS stock under the Base Case scenario is 56.98 EUR. Compared to the current market price of 24.2 EUR, Stratec SE is Undervalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBS Relative Value
Base Case
56.98 EUR
Undervaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
95
vs Industry
59
Median 3Y
2.2
Median 5Y
3.7
Industry
2.2
Forward
1.1
More Details
29.4
P/E
P/E
Price to Earnings
29.4
vs History
92
vs Industry
18
Median 3Y
36.8
Median 5Y
38.4
Industry
21.8
Forward
16.6
More Details
8.6
P/OCF
P/OCF
Price to OCF
8.6
vs History
85
vs Industry
38
Median 3Y
19.1
Median 5Y
27
Industry
13.5
More Details
18.6
P/FCFE
P/FCFE
Price to FCFE
18.6
vs History
77
vs Industry
23
Median 3Y
27.3
Median 5Y
61.3
Industry
19.8
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
95
vs Industry
53
Median 3Y
2.5
Median 5Y
4.7
Industry
2.1
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
95
vs Industry
56
Median 3Y
2.4
Median 5Y
3.9
Industry
2.3
Forward
1.4
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
95
vs Industry
40
Median 3Y
10
Median 5Y
13.3
Industry
4.8
More Details
9.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.2
vs History
95
vs Industry
33
Median 3Y
15.6
Median 5Y
18.6
Industry
11.5
Forward
8.6
More Details
18.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.5
vs History
95
vs Industry
23
Median 3Y
25.5
Median 5Y
27.7
Industry
15.7
Forward
12.9
More Details
10.3
EV/OCF
EV/OCF
Enterprise Value to OCF
10.3
vs History
85
vs Industry
34
Median 3Y
19.8
Median 5Y
29.6
Industry
13.5
More Details
19.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.2
vs History
61
vs Industry
22
Median 3Y
22.9
Median 5Y
29.9
Industry
17.6
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
95
vs Industry
60
Median 3Y
1.5
Median 5Y
3
Industry
1.8
More Details

Multiples Across Competitors

SBS Competitors Multiples
Stratec SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Stratec SE
XETRA:SBS
294.2m EUR 1.2 29.4 9.2 18.5
US
Abbott Laboratories
NYSE:ABT
222.5B USD 5.3 16.5 21.4 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
201.6B USD 23.1 81.4 65.2 78.4
US
Boston Scientific Corp
NYSE:BSX
152.3B USD 8.7 74.9 35.3 49.2
US
Stryker Corp
NYSE:SYK
147.6B USD 6.4 51.6 25.5 30.7
IE
Medtronic PLC
NYSE:MDT
108.1B USD 3.3 25.4 13.6 19.2
DE
Siemens Healthineers AG
XETRA:SHL
54.4B EUR 2.3 26 14.5 20.1
US
Becton Dickinson and Co
NYSE:BDX
49B USD 2.3 32.3 13 24.2
US
Edwards Lifesciences Corp
NYSE:EW
45.2B USD 8.2 10.8 24.7 27.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.1B USD 10.5 46 32.6 36.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
281.2B CNY 7.9 25.2 22.1 22.1

See Also

Summary
SBS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBS stock valuation using valuation multiples.
Wall Street Estimates
SBS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 254,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.